News | July 29, 2025
Astec LifeSciences Q1 FY26 revenue up 30.3%
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
The facility will manufacture 13,200 MTPA Benzyl Chloride, 9,600 MTPA Benzyl Alcohol, and 7,200 MTPA Benzaldehyde
The study showed that sClever-1 is released by macrophages and blood vessel cells and binds to activated T cells
Lyfius Pharma restarts operations at Penicillin-G manufacturing facility
Label updates reflect growing body of real-world evidence and regulatory confidence in the safety profile of the class of CD19- and BCMA-directed autologous CAR T cell therapies, reinforcing efforts to increase equitable access
WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy
Subscribe To Our Newsletter & Stay Updated
